ESC 365 - How much can ejection fraction be improved in patients with heart failure with reduced ejection fraction (HFrEF) by the early introduction of evidence-based heart failure medication?

HFA Premium Access

How much can ejection fraction be improved in patients with heart failure with reduced ejection fraction (HFrEF) by the early introduction of evidence-based heart failure medication?

Session: ePosters in chronic heart failure - pharmacotherapy 3

Topic: Pharmacotherapy

Speaker: Doctor J. White (London, GB)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Joseph White

Homerton University Hospital, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

How low can early introduction of evidence based heart failure medications drive readmission rates?

Speaker: Doctor T. Caspi (London, GB)

Heart rate management practices in HFrEF among Indian cardiologists: Role of beta-blocker and ivabradine-based therapy

Speaker: Doctor V. Kolapkar (Mumbai, IN)

Myocardial ketone body oxidation underlies the salutary effects of SGLT2 inhibitor treatment in heart failure

Speaker: Ms S. Voorrips (Groningen, NL)

The effect of add-on Ivabradine in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials and real-world data

Speaker: Doctor C. Liao (Tainan, TW)

Early treatment of heart failure: a non-interventional observational study programme of patients with heart failure and initiated on dapagliflozin (EVOLUTION HF)

Speaker: Doctor S. Adamsson Eryd (SE)

Access the full session

ePosters in chronic heart failure - pharmacotherapy 3

Speakers: Doctor J. White, Doctor T. Caspi, Doctor V. Kolapkar, Ms S. Voorrips, Doctor C. Liao...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources